20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T9989 | AChE-IN-27 | Others | |
AChE-IN-27 is a small molecule used for high-throughput assays. | |||
T12421 | PF-04885614 | Sodium Channel | |
PF-04885614 is a potent inhibitor of NaV1.8, has potential for neurological and neurodevelopmental diseases treatment. | |||
T8944 | TTA-A2 | Calcium Channel | |
TTA-A2 is a selective T-type calcium channel antagonist as a potent anticonvulsant that the Cav3.1 isoform plays a prominent role in mediating. TTA-A2 is equally potent against the Cav3.1 (a1G) and Cav3.2 (a1H) channels ... | |||
T8930 | CID44216842 | KUC103479N-02 | CDK , Ras |
CID44216842 (KUC103479N-02) is a potent Cdc42-selective guanine nucleotide binding lead inhibitor. The EC50s for Cdc42 WT and Cdc42Q61L mutant are 1.0 and 1.2 μM in GTP binding assay, respectively. The EC50s for Cdc42 WT... | |||
T3198L | PRE-084 hydrochloride | Sigma receptor | |
PRE-084 hydrochloride is a selective agonist of σ1(IC50:44 nM, in the sigma receptor assay). | |||
T14390 | Azelaprag | AMG 986 | Apelin receptor |
Azelaprag (AMG 986) is an effective small-molecule apelin receptor agonist. Azelaprag can be used to treat neurological diseases and cardiovascular diseases. | |||
T22850 | ICI 204,448 | ICI 204448,ICI204448,ICI-204448 | Opioid Receptor |
ICI 204,448 is a potent κ-opioid agonist with potential analgesic activity for the study of neurological diseases. | |||
T30998L | COG-1410 acetate | COG-1410 acetate(878009-24-6 Free base) | Apoptosis |
COG-1410 acetate is an apolipoprotein E-derived peptide and can be used in studies about neurological diseases. | |||
T15553 | Iganidipine | NKY 722 | Calcium Channel |
Iganidipine(NKY 722) is a new water-soluble Ca2+ antagonist with antihypertensive activity for research and neurological related diseases. | |||
T68143 | Solpecainol | Sodium Channel | |
solpecainol is a sodium channel blocker used in the study of neurological and cardiovascular diseases. | |||
T60908 | SARM1-IN-2 | Others | |
SARM1-IN-2 is a potent SARM1 inhibitor for the study of metabolic and neurological related diseases. | |||
T17211 | Vafidemstat | ORY-2001 | Histone Demethylase , MAO |
Vafidemstat (ORY-2001) is a selective, orally active lysyl-histone demethylase (LSD1)/MAO-B inhibitor that crosses the blood-brain barrier for the study of neurological diseases. | |||
T2192 | Indazole | Sodium Channel | |
Indazole is also called benzpyrazole or isoindazone. Its derivatives exhibit a wide range of biological activities. Indazole and its derivatives can be used in the research of cancer, neurological diseases, cardiovascula... | |||
T27830L | Lifarizine FA | Lifarizine FA(119514-66-8 Free base) | Sodium Channel |
Lifarizine FA is a sodium channel blocker used in the treatment of neurological disorders and cardiovascular diseases, study of stroke. | |||
T9694 | Emraclidine | CVL-231 | AChR |
Emraclidine (CVL-231) is a muscarinic M4 receptor positive allosteric modulator and can be used in neurological diseases studies. | |||
TP2417 | Tidembersat | Others | |
Tidembersat is a small molecule compound used to treat and/or prevent degenerative diseases such as Huntington's chorea, schizophrenia, neurological. | |||
T40042 | Evifacotrep | TRP/TRPV Channel | |
Evifacotrep is a short transient receptor potential channel 5 ( TRPC5 ) antagonist (WO2020061162, compound 100). Evifacotrep can be used for the research of neurological diseases. | |||
T13419 | ROCK-IN-1 | ROCK | |
ROCK-IN-1 is a potent ROCK inhibitor that inhibits ROCK2-mediated signaling with an IC50 value of 1.2 nM.ROCK-IN-1 can be used in the study of neurological disorders and inflammation-related diseases. | |||
T78825 | D4R agonist-1 | Dopamine Receptor | |
D4R agonist-1 is a selective and potent D4R partial agonist (Ki:2.2 nM).D4R agonist-1 can be used to study neurological diseases. | |||
T67938 | PROT-IN-1 | Others | |
PROT-IN-1 is a potent high-affinity inhibitor of L-proline transporter and a candidate compound for the treatment of neurological diseases. |